This is a dedicated cardiac Siemens 1.5T MRI system installed at the Baylor Scott White Heart Hospital in Dallas.

Miami Cardiac & Vascular Institute announced the implementation of Philips’ Ingenia Ambition 1.5T MR, the world’s first magnetic resonance imaging (MRI) system to enable helium-free operations. The technology offers cutting-edge imaging techniques that deliver high-quality images faster while providing an improved, more comfortable experience for patients, according to Philips.

Brain images that have been pre-reviewed by the Viz.AI artificial intelligence software to identify a stroke. The software automatically sends and alert to the attending physician's smartphone with links to the imaging for a final human assessment to help speed the time to diagnosis and treatment. Depending on the type of stroke, quick action is needed to either activate the neuro-interventional lab or to administer tPA.

With its increasing role in medical imaging, artificial intelligence (AI) gradually is becoming a go-to technology for building custom healthcare software to diagnose a wide range of diseases, from diabetic retinopathy to skin cancer.

Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b cardiovascular imaging study in patients suffering from coronary artery disease using the company's new one-vial Oncardia (ethylenedicysteine-glucosamine) kits.  The 60-patient trial study is being conducted in the U.S.

3 Recommendations to Better Understand HIPAA Compliance

According to the U.S. Department of Health and Human Services (HHS), about 70 percent of organizations are not compliant with the Health Insurance Portability and Accountability Act of 1996 (HIPAA). 
HIPAA mandates industry-wide standards for healthcare information and electronic billing, and requires protection as well as confidential handling of protected health information.

May 17, 2019 — The U.S. Food and Drug Administration (FDA) this week approved Fragmin (dalteparin sodium) injection, for subcutaneous use, to reduce the recurrence of symptomatic venous thromboembolism (VTE) in pediatric patients one month of age and older. VTE can include deep vein thrombosis (DVT) and pulmonary embolism (PE), which can lead to death.

Digital healthcare company Murj announced the availability of the Murj Analytics software-as-a-service (SaaS) platform for cardiac implantable electronic device (CIED) management. This new offering features powerful intelligence for cardiac device clinicians seeking to provide comprehensive population management through improved clinical, workforce and quality of care metrics.

At the 40th annual Heart Rhythm Scientific Sessions, May 8-11 in San Francisco, Acutus Medical announced the agreement to acquire Rhythm Xience Inc., and new strategic partnerships with Peerbridge Health, Cardiac Designs and MedFact. Acutus' expanded portfolio builds on the organization's mapping and visualization technology platform.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now